Lexaria Bioscience Corp. SEC filings LEXX

Lexaria Bioscience Corp. has 1,000 filings in SEC EDGAR's recent list, going back to Aug 25, 2009. Its latest annual report, Form 10-K, was filed on Nov 28, 2025 for the period ended Aug 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 13, 2026, covering the quarter ended May 31, 2026. The most recent current report (Form 8-K) was filed on Sep 9, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on August 31.

Lexaria Bioscience Corp. SEC filings
Form Description Filed Period
424B3 Prospectus Oct 13, 2026 —
S-3 Shelf registration Oct 2, 2026 —
S-8 Employee stock plan registration Jan 28, 2026 —
424B3 Prospectus Jan 14, 2026 —
S-3 Shelf registration Dec 29, 2025 —
424B5 Prospectus supplement Dec 16, 2025 —
424B3 Prospectus Dec 9, 2025 —
POS AM Filing Dec 5, 2025 —
S-1/A Amended registration statement Dec 5, 2025 —
S-1 Registration statement Oct 14, 2025 —
424B5 Prospectus supplement Sep 29, 2025 —
424B5 Prospectus supplement Apr 28, 2025 —
424B5 Prospectus supplement Feb 5, 2025 —
S-3 Shelf registration Jan 22, 2025 —
S-8 Employee stock plan registration Jan 6, 2025 —
POS AM Filing Dec 16, 2024 —
424B3 Prospectus Dec 5, 2024 —
S-3 Shelf registration Nov 26, 2024 —
424B5 Prospectus supplement Oct 16, 2024 —
424B5 Prospectus supplement Aug 21, 2024 —
424B3 Prospectus Jun 11, 2024 —
S-1 Registration statement Jun 3, 2024 —
424B3 Prospectus Mar 20, 2024 —
S-1 Registration statement Mar 12, 2024 —
424B5 Prospectus supplement Feb 16, 2024 —
POS AM Filing Jan 24, 2024 —
S-8 Employee stock plan registration Jan 18, 2024 —
424B3 Prospectus Dec 8, 2023 —
S-1 Registration statement Nov 30, 2023 —
424B5 Prospectus supplement Oct 2, 2023 —
424B4 Prospectus May 10, 2023 —
S-1/A Amended registration statement Apr 28, 2023 —
S-1 Registration statement Apr 3, 2023 —
POS AM Filing Dec 28, 2022 —
POS AM Filing Dec 21, 2022 —
424B5 Prospectus supplement Aug 12, 2022 —
S-3 Shelf registration Jan 28, 2022 —
424B3 Prospectus Dec 28, 2021 —
424B3 Prospectus Dec 28, 2021 —
POS AM Filing Dec 17, 2021 —
POS AM Filing Dec 17, 2021 —
S-8 Employee stock plan registration Jul 30, 2021 —
424B3 Prospectus Mar 3, 2021 —
POS AM Filing Feb 26, 2021 —
POS AM Filing Feb 12, 2021 —
424B4 Prospectus Jan 14, 2021 —
S-1MEF Form s-1mef Jan 11, 2021 —
S-1/A Amended registration statement Jan 7, 2021 —
S-1/A Amended registration statement Jan 6, 2021 —
S-1 Registration statement Nov 20, 2020 —
424B3 Prospectus Jun 12, 2020 —
424B3 Prospectus Jun 11, 2020 —
S-1 Registration statement Jun 3, 2020 —
S-8 Employee stock plan registration May 17, 2019 —
S-8 Employee stock plan registration Apr 30, 2019 —
424B3 Prospectus Apr 9, 2018 —
S-4/A Filing Mar 1, 2018 —
S-4/A Form s-4/a Feb 7, 2018 —
S-4 Registration for a merger or exchange Jan 5, 2018 —
424B3 Prospectus Jul 3, 2012 —
S-1/A Amended registration statement Jun 22, 2012 —
S-1/A Amended registration statement May 31, 2012 —
S-1 Registration statement Mar 15, 2012 —
424B3 Prospectus Aug 5, 2011 —
S-1 Registration statement Jul 21, 2011 —
S-8 Employee stock plan registration Jul 7, 2011 —

Showing 66 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LEXX (Nasdaq)
Fiscal year ends
August 31
Incorporated in
NV
Headquarters
Kelowna, British Columbia, Canada
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1348362
Former names
Lexaria Corp. (until May 11, 2016); LEXARIA CORP. (until May 11, 2016)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.